Volume 28, Issue 3 pp. 300-301

‘INDOTEST’ in atypical hemicrania continua

F Baldacci

Corresponding Author

F Baldacci

Department of Neurosciences, University of Pisa, Pisa, and

Filippo Baldacci, MD, Department of Neurosciences, University of Pisa, Via Roma 67, Pisa, Italy. Tel. + 39 058 4605 9539, fax + 39 058 4605 9537, e-mail [email protected]Search for more papers by this author
A Nuti

A Nuti

Neurology Unit, Hospital of Viareggio (LU), Viareggio, Italy

Search for more papers by this author
G Cafforio

G Cafforio

Neurology Unit, Hospital of Viareggio (LU), Viareggio, Italy

Search for more papers by this author
C Lucetti

C Lucetti

Neurology Unit, Hospital of Viareggio (LU), Viareggio, Italy

Search for more papers by this author
C Logi

C Logi

Neurology Unit, Hospital of Viareggio (LU), Viareggio, Italy

Search for more papers by this author
G Cipriani

G Cipriani

Neurology Unit, Hospital of Viareggio (LU), Viareggio, Italy

Search for more papers by this author
G Orlandi

G Orlandi

Department of Neurosciences, University of Pisa, Pisa, and

Search for more papers by this author
U Bonuccelli

U Bonuccelli

Department of Neurosciences, University of Pisa, Pisa, and

Search for more papers by this author
First published: 31 January 2008
Citations: 4

Abstract

Hemicrania continua (HC) is an indomethacin-responsive headache characterized by a chronic, strictly unilateral, side-locked without side-shifting, persistent headache. We report three cases of HC with atypical features in which an acute administration of indomethacin 50 mg IM (INDOTEST) was performed. In all three cases INDOTEST predicted chronic responsiveness to indomethacin. Thus, in cases of HC with atypical features, INDOTEST could help for a correct diagnosis and therapy.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.